Not Every Hit‐Identification Technique Works on 1‐Deoxy‐d‐Xylulose 5‐Phosphate Synthase (DXPS): Making the Most of a Virtual Screening Campaign

Author:

Johannsen Sandra12ORCID,Gierse Robin M.123ORCID,Olshanova Aleksandra1ORCID,Smerznak Ellie1,Laggner Christian4ORCID,Eschweiler Lea1ORCID,Adeli Zahra1ORCID,Hamid Rawia12ORCID,Alhayek Alaa12ORCID,Reiling Norbert56ORCID,Haupenthal Jörg1ORCID,Hirsch Anna K. H.123ORCID

Affiliation:

1. Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) Campus Building E8.1 66123 Saarbrücken Germany

2. Department of Pharmacy Saarland University Campus Building E8.1 66123 Saarbrücken Germany

3. Stratingh Institute for Chemistry University of Groningen Nijenborgh 7 9747 AG Groningen (The Netherlands

4. Atomwise Inc. 717 Market Street, Suite 800 San Francisco CA 94103 USA

5. RG Microbial Interface Biology Research Center Borstel Leibniz Lung Center Borstel Germany

6. German Center for Infection Research (DZIF) Partner site Hamburg-Lübeck-Borstel-Riems Borstel Germany

Abstract

AbstractIn this work, we demonstrate how important it is to investigate not only on‐target activity but to keep antibiotic activity against critical pathogens in mind. Since antimicrobial resistance is spreading in bacteria such as Mycobacterium tuberculosis, investigations into new targets are urgently needed. One promising new target is 1‐deoxy‐d‐xylulose 5‐phosphate synthase (DXPS) of the 2‐C‐methyl‐d‐erythritol 4‐phosphate (MEP) pathway. We have recently solved the crystal structure of truncated M. tuberculosis DXPS and used it to perform a virtual screening in collaboration with Atomwise Inc. using their deep convolutional neural network‐based AtomNet® platform. Of 94 virtual hit compounds only one showed interesting results in binding and activity studies. We synthesized 30 close derivatives using a straightforward synthetic route that allowed for easy derivatization. However, no improvement in activity was observed for any of the derivatives. Therefore, we tested them against a variety of pathogens and found them to be good inhibitors against Escherichia coli.

Funder

European Research Council

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference50 articles.

1. J. O′Neill “Tackling Drug-Resistent Infections Globally: Final Report and Recommendations” can be found underhttps://amr-review.org/sites/default/files/160518 Final%20paper with%20cover.pdf 2016.

2. World Health Organisation “WHO publishes list of bacteria for which new antibiotics are urgently needed” can be found underhttp://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed 2017.

3. World Health Organisation Prioritization of pathogens to guide discovery research and development of new antibiotics for drug-resistant bacterial infections including tuberculosis Geneva 2017.

4. Management of drug-resistant tuberculosis

5.  

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3